HCA Healthcare, Inc. (HCA)

From the record

HCA Healthcare, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

HCA Healthcare, Inc.'s 7 filed years say what it did: revenue went from $51 billion in fiscal 2019 to $76 billion in fiscal 2025, up 6.7% a year; it rose in 6 of 6 years; it never fell from a peak; net income was positive in 7 of 7 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, HCA Healthcare, Inc.'s diluted share count shrank about 6.7% a year, and dividends and buybacks returned about 67% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 22 sales and 0 purchases of their own stock on the open market in the year to 2026-11-10 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, HCA Healthcare, Inc.'s shareholders' equity was below zero, so the profit on it is not read. Leverage: it owed about 105 cents per dollar of assets, and net share issuance: its share count shrank 8.5% over the year (the filed statements).

From the record

HCA Healthcare, Inc.'s standing among 22 graded names in its industry family: revenue of $76 billion in fiscal 2025 ranks in the top 2% by size; a net margin of 9% ranks in the top 20%; revenue growth of 7.9% a year over the last 3 filed years ranks in the bottom 43% (its annual reports).

From the record

HCA Healthcare, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Hazen, Samuel N (CEO, as filed), filing under that title since 2019-02-01, 7.8 years (top 29% of its family); the 18 officers and directors filing in the last fifteen months have been on the record a median of 11.1 years (top 3%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 18 people in charge now (top 50%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

HCA Healthcare, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $1.0 billion against debt of $44 billion leaves -71.2% of its assets as net cash, bottom 12% of its family; cash from operations less capital spending is 10.2% of revenue (top 20%) (its annual report).

From the record

HCA Healthcare, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 7.9% a year over the last three filed years against 6.7% over all 7, speeding up (bottom 48% of its family); the newest year grew 7.1% (bottom 43%); capital spending grew 4% a year (top 50%) (its annual reports). HCA Healthcare, Inc. reported 3 lines of business in fiscal 2025: American Group at $26 billion, Atlantic Group at $25 billion, National Group at $21 billion. 3 of 3 grew in the latest filed year, and the largest line is 37% of revenue (its annual report).

From the record

HCA Healthcare, Inc.'s newest year against its own record: revenue of $76 billion in fiscal 2025 came in 1.1% below the $76 billion its prior three years' pace pointed to (bottom 39% of its family); net income of $6.8 billion against a prior three-year average of $5.5 billion (bottom 43%); a net margin of 9% against 8.5% before (bottom 48%) (its annual reports).